Craft

Endonovo Therapeutics

Stock Price

$0

2024-10-29

Market Capitalization

$396.8 K

2024-10-29

Revenue

$135.4 K

FY, 2022

Endonovo Therapeutics Summary

Company Summary

Overview
Endonovo Therapeutics is a biotechnology company that develops bioelectronic therapies and products for regenerative medicine. It provides medical devices focused on the healing of wounds and reduction of pain, edema, and inflammation. The devices are designed to deliver the company's proprietary electroceutical therapy for the treatment of inflammatory conditions, cardiovascular diseases, and central nervous system disorders.
Type
Public
Status
Active
Founded
2011
HQ
Los Angeles, CA, US | view all locations
Website
http://endonovo.com/
Cybersecurity rating
Sectors

Key People

  • Alan Collier, Chairman & Chief Executive Officer

    LocationsView all

    1 location detected

    • Los Angeles, CA HQ

      United States

      6320 Canoga Ave 15th Floor, Woodland Hills

    Endonovo Therapeutics Financials

    Summary Financials

    Revenue (Q3, 2023)
    $1.5K
    Gross profit (Q3, 2023)
    $693.0
    Net income (Q3, 2023)
    ($766.2K)
    EBIT (Q3, 2023)
    ($472.8K)

    Footer menu